vs
Side-by-side financial comparison of CARRIAGE SERVICES INC (CSV) and Protagonist Therapeutics, Inc (PTGX). Click either name above to swap in a different company.
Protagonist Therapeutics, Inc is the larger business by last-quarter revenue ($170.6M vs $105.5M, roughly 1.6× CARRIAGE SERVICES INC). Protagonist Therapeutics, Inc runs the higher net margin — 77.2% vs 11.6%, a 65.5% gap on every dollar of revenue. On growth, Protagonist Therapeutics, Inc posted the faster year-over-year revenue change (184.4% vs 8.0%). Protagonist Therapeutics, Inc produced more free cash flow last quarter ($182.8M vs $6.2M).
Jardine Cycle & Carriage Limited is the investment holding company of Jardines in Southeast Asia. It is currently 75% held by the conglomerate.
Protagonist Therapeutics, Inc. is a clinical-stage biopharmaceutical company focused on discovering and developing novel peptide-based targeted therapies for unmet medical needs, primarily covering gastrointestinal disorders, inflammatory diseases and rare disease indications. Its lead product candidates target inflammatory bowel disease and other chronic immune-related conditions, with operations spanning global R&D and partnership collaborations.
CSV vs PTGX — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2024
| Metric | | |
|---|---|---|
| Revenue | $105.5M | $170.6M |
| Net Profit | $12.3M | $131.7M |
| Gross Margin | 34.8% | — |
| Operating Margin | 23.3% | 74.3% |
| Net Margin | 11.6% | 77.2% |
| Revenue YoY | 8.0% | 184.4% |
| Net Profit YoY | 24.5% | 381.7% |
| EPS (diluted) | $0.76 | $2.01 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $105.5M | — | ||
| Q3 25 | $102.7M | — | ||
| Q2 25 | $102.1M | — | ||
| Q1 25 | $107.1M | — | ||
| Q4 24 | $97.7M | $170.6M | ||
| Q3 24 | $100.7M | — | ||
| Q2 24 | $102.3M | — | ||
| Q1 24 | $103.5M | $255.0M |
| Q4 25 | $12.3M | — | ||
| Q3 25 | $6.6M | — | ||
| Q2 25 | $11.7M | — | ||
| Q1 25 | $20.9M | — | ||
| Q4 24 | $9.9M | $131.7M | ||
| Q3 24 | $9.9M | — | ||
| Q2 24 | $6.3M | — | ||
| Q1 24 | $7.0M | $207.3M |
| Q4 25 | 34.8% | — | ||
| Q3 25 | 35.3% | — | ||
| Q2 25 | 35.2% | — | ||
| Q1 25 | 35.3% | — | ||
| Q4 24 | 34.4% | — | ||
| Q3 24 | 35.2% | — | ||
| Q2 24 | 36.2% | — | ||
| Q1 24 | 36.0% | — |
| Q4 25 | 23.3% | — | ||
| Q3 25 | 17.0% | — | ||
| Q2 25 | 23.5% | — | ||
| Q1 25 | 29.5% | — | ||
| Q4 24 | 21.6% | 74.3% | ||
| Q3 24 | 22.7% | — | ||
| Q2 24 | 18.0% | — | ||
| Q1 24 | 18.8% | 80.9% |
| Q4 25 | 11.6% | — | ||
| Q3 25 | 6.4% | — | ||
| Q2 25 | 11.5% | — | ||
| Q1 25 | 19.5% | — | ||
| Q4 24 | 10.1% | 77.2% | ||
| Q3 24 | 9.8% | — | ||
| Q2 24 | 6.1% | — | ||
| Q1 24 | 6.7% | 81.3% |
| Q4 25 | $0.76 | — | ||
| Q3 25 | $0.41 | — | ||
| Q2 25 | $0.74 | — | ||
| Q1 25 | $1.34 | — | ||
| Q4 24 | $0.62 | $2.01 | ||
| Q3 24 | $0.63 | — | ||
| Q2 24 | $0.40 | — | ||
| Q1 24 | $0.45 | $3.26 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $1.7M | $418.9M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $254.8M | $675.3M |
| Total Assets | $1.3B | $744.7M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $1.7M | — | ||
| Q3 25 | $1.2M | — | ||
| Q2 25 | $1.4M | — | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $1.2M | $418.9M | ||
| Q3 24 | $1.3M | — | ||
| Q2 24 | $1.5M | — | ||
| Q1 24 | $1.7M | $322.6M |
| Q4 25 | $254.8M | — | ||
| Q3 25 | $242.1M | — | ||
| Q2 25 | $235.4M | — | ||
| Q1 25 | $223.1M | — | ||
| Q4 24 | $208.6M | $675.3M | ||
| Q3 24 | $198.1M | — | ||
| Q2 24 | $187.9M | — | ||
| Q1 24 | $179.6M | $560.4M |
| Q4 25 | $1.3B | — | ||
| Q3 25 | $1.3B | — | ||
| Q2 25 | $1.3B | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | $744.7M | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.3B | — | ||
| Q1 24 | $1.3B | $629.3M |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $14.1M | $184.2M |
| Free Cash FlowOCF − Capex | $6.2M | $182.8M |
| FCF MarginFCF / Revenue | 5.9% | 107.1% |
| Capex IntensityCapex / Revenue | 7.5% | 0.8% |
| Cash ConversionOCF / Net Profit | 1.15× | 1.40× |
| TTM Free Cash FlowTrailing 4 quarters | $40.1M | $101.7M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $14.1M | — | ||
| Q3 25 | $24.7M | — | ||
| Q2 25 | $8.1M | — | ||
| Q1 25 | $13.8M | — | ||
| Q4 24 | $9.3M | $184.2M | ||
| Q3 24 | $20.9M | — | ||
| Q2 24 | $2.2M | — | ||
| Q1 24 | $19.7M | $-27.4M |
| Q4 25 | $6.2M | — | ||
| Q3 25 | $18.0M | — | ||
| Q2 25 | $5.2M | — | ||
| Q1 25 | $10.6M | — | ||
| Q4 24 | $4.9M | $182.8M | ||
| Q3 24 | $16.2M | — | ||
| Q2 24 | $-1.4M | — | ||
| Q1 24 | $16.2M | $-27.7M |
| Q4 25 | 5.9% | — | ||
| Q3 25 | 17.5% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 9.9% | — | ||
| Q4 24 | 5.0% | 107.1% | ||
| Q3 24 | 16.1% | — | ||
| Q2 24 | -1.4% | — | ||
| Q1 24 | 15.6% | -10.9% |
| Q4 25 | 7.5% | — | ||
| Q3 25 | 6.5% | — | ||
| Q2 25 | 2.8% | — | ||
| Q1 25 | 3.0% | — | ||
| Q4 24 | 4.5% | 0.8% | ||
| Q3 24 | 4.6% | — | ||
| Q2 24 | 3.5% | — | ||
| Q1 24 | 3.4% | 0.1% |
| Q4 25 | 1.15× | — | ||
| Q3 25 | 3.76× | — | ||
| Q2 25 | 0.69× | — | ||
| Q1 25 | 0.66× | — | ||
| Q4 24 | 0.94× | 1.40× | ||
| Q3 24 | 2.11× | — | ||
| Q2 24 | 0.34× | — | ||
| Q1 24 | 2.83× | -0.13× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSV
| Propertyand Merchandise | $47.8M | 45% |
| Cemetery Interment Rights | $24.8M | 23% |
| Merchandise | $18.9M | 18% |
| Other Revenue | $10.2M | 10% |
| Other | $3.9M | 4% |
PTGX
Segment breakdown not available.
